Abstract

460,000 new cases of pancreatic cancer in 2018. The congress will focus on translational and clinical pancreatic cancer research including sessions on diagnostics, screening and therapy. Additional topics such as genetic testing, immunology and immunotherapy, management of local disease, etabolism and metabolomics, precision medicine, signaling and oncogenes as well as the tumor microenvironment will be presented.